The American Diabetes Journal has details on an interesting NRF2 study currently in progress. Diabetes is a huge concern to many individuals and families. According to statistics published by the American Diabetes Association more than 25.8 million...read more
Professor Matthew Walker and his fellow researchers, at University College London (UCL), have some promising early evidence in epilepsy and NRF2 research. Their research targets two approaches, 1) By targeting anti-oxidant treatments to inhibit the enzymes that...read more
Obesity: A Growing Epidemic The Center for Disease Control (CDC) states that obesity is a significant public health problem. The "Healthy People" initiative shows that not one state in the United States meets the Healthy People goal of 15% body mass index (BMI)....read more
There has been an increased awareness and many resulting questions following Angelina Jolie's announcement that she has had a preventative double mastectomy to prevent the further spread of cancer. The gene within her body that led to her decision is...read more
A classic NRF2 study entitled, "Nrf2, a multi-organ protector?" predates many of the latest studies regarding NRF2. It was however one of those landmark studies that paved the way for later studies. The study states, "Nrf2 may serve as a master...read more
Our original article highlighting the Michael J. Fox Foundation's interest in NRF2 activation solutions for Parkinson's disease met with a lot of interest, so we decided to do a follow up piece highlighting an additional study that is currently underway. This time,...read more
Our mission is to provide an impartial review of the emerging research regarding Nrf2 activation.
We welcome the involvement of those who have published peer review studies in this field.
Should you wish to contact us, please leave a message using the adjacent form.